By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



22 Rue Garnier

Neuilly Sur Seine    92200  France
Phone: N/A Fax:




Company News
Servier Release: Patients With Advanced Metastatic Colorectal Cancer In Europe Now Have A New Treatment Option As LONSURF(Trifluridine/Tipiracil) Receives EU Approval 4/27/2016 9:57:34 AM
Servier Receives Positive CHMP Opinion For LONSURF (Trifluridine/Tipiracil) For Refractory Metastatic Colorectal Cancer 2/26/2016 9:57:43 AM
Spectrum Pharma (SPPI) Signs A Strategic Partnership With Servier Canada 1/11/2016 1:00:22 PM
Cellectis (ALCLS) Announces Conference Call To Discuss UCART19 Development Collaboration With Pfizer (PFE) And Servier 12/4/2015 10:42:44 AM
Servier Slashes 610 Jobs in Company Reorganization 11/30/2015 6:02:04 AM
Galapagos (GLPG.BR) Initiates Phase 1 First-In-Human Study With GLPG1972, Receives €3.5 Million Milestone From Servier 11/20/2015 9:00:53 AM
Servier Exercises Exclusive Worldwide Licensing Option With Cellectis (ALCLS) For UCART19, An Allogeneic CAR-T Cell Therapy For Hematological Malignancies 11/19/2015 11:58:48 AM
Pfizer (PFE), Servier Snap Up Right to Cellectis (ALCLS)' Blood Cancer Therapy in $338 Million+ Deal 11/19/2015 5:57:59 AM
Servier Walks Away from a $450 Million Cancer Deal with MacroGenics, Inc. (MGNX) 10/29/2015 7:33:23 AM
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Servier 6/19/2015 10:26:57 AM